Hopital Prive De L'Estuaire
- Address
- 505 Rue Irene Joliot Curie, 76620 Le Havre, France
Hopital Prive De L'Estuaire - Oncology and Cardiovascular Research Center
Hopital Prive De L'Estuaire is a clinical research facility conducting advanced phase III trials across multiple therapeutic areas. The center demonstrates particular expertise in precision oncology and cardiovascular interventional medicine, with a strong focus on optimizing treatment strategies through innovative therapeutic de-escalation and personalized medicine approaches.
- Advanced breast cancer research, including triple-negative breast cancer (TNBC) and hormone receptor-positive disease with personalized immunotherapy and targeted therapy protocols
- Gastrointestinal malignancies, specifically locally advanced anal squamous cell carcinoma treatment optimization
- Cardiovascular interventional studies focused on antiplatelet therapy strategies in elderly patients undergoing percutaneous coronary intervention (PCI)
The center's research portfolio emphasizes treatment de-escalation strategies and non-inferiority trial designs, reflecting a commitment to identifying optimal therapeutic regimens that balance efficacy with patient safety and quality of life. Their oncology programs investigate novel approaches combining immunotherapy, targeted agents like CDK4/6 inhibitors, and conventional chemotherapy, while their cardiovascular research addresses critical questions about dual antiplatelet therapy (DAPT) duration in vulnerable elderly populations with acute and chronic coronary syndromes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hopital Prive De L'Estuaire
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Adjuvant Pembrolizumab Versus Observation in Early Triple-Negative Breast Cancer with Pathologic Complete Response Post-Neoadjuvant Therapy | Unicancer | Phase III | Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Docetaxel | 2 | Unknown | 2024-02-26 | 2025-12-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.